These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19932165)

  • 21. The Peroxisome Proliferator-Activated Receptor (PPAR)-
    Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
    Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.
    Schopfer FJ; Lin Y; Baker PR; Cui T; Garcia-Barrio M; Zhang J; Chen K; Chen YE; Freeman BA
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2340-5. PubMed ID: 15701701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion.
    Rudolph V; Rudolph TK; Schopfer FJ; Bonacci G; Woodcock SR; Cole MP; Baker PR; Ramani R; Freeman BA
    Cardiovasc Res; 2010 Jan; 85(1):155-66. PubMed ID: 19666678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additive regulation of adiponectin expression by the mediterranean diet olive oil components oleic Acid and hydroxytyrosol in human adipocytes.
    Scoditti E; Massaro M; Carluccio MA; Pellegrino M; Wabitsch M; Calabriso N; Storelli C; De Caterina R
    PLoS One; 2015; 10(6):e0128218. PubMed ID: 26030149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor gamma agonist alleviates the symptoms of DSS-induced colitis.
    Yamamoto K; Ninomiya Y; Iseki M; Nakachi Y; Kanesaki-Yatsuka Y; Yamanoue Y; Itoh T; Nishii Y; Petrovsky N; Okazaki Y
    Biochem Biophys Res Commun; 2008 Mar; 367(3):566-72. PubMed ID: 18191038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by nitroalkene fatty acids: importance of nitration position and degree of unsaturation.
    Gorczynski MJ; Smitherman PK; Akiyama TE; Wood HB; Berger JP; King SB; Morrow CS
    J Med Chem; 2009 Aug; 52(15):4631-9. PubMed ID: 19719236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist.
    Linard C; Grémy O; Benderitter M
    J Pharmacol Exp Ther; 2008 Mar; 324(3):911-20. PubMed ID: 18077625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PGlyRP3 concerts with PPARγ to attenuate DSS-induced colitis in mice.
    Hyder A
    Int Immunopharmacol; 2019 Feb; 67():46-53. PubMed ID: 30530168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of peroxisome proliferator-activated receptor gamma activation in mice.
    Guo X; Xu K; Zhang J; Li H; Zhang W; Wang H; Lange AJ; Chen YE; Huo Y; Wu C
    J Biol Chem; 2010 Jul; 285(31):23711-20. PubMed ID: 20498376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A soybean and fish oil mixture with different n-6/n-3 PUFA ratios modulates the inflammatory reaction in mice with dextran sulfate sodium-induced acute colitis.
    Huang CH; Hou YC; Yeh CL; Yeh SL
    Clin Nutr; 2015 Oct; 34(5):1018-24. PubMed ID: 25434577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction.
    Ponferrada A; Caso JR; Alou L; Colón A; Sevillano D; Moro MA; Lizasoain I; Menchén P; Gómez-Lus ML; Lorenzo P; Cos E; Leza JC; Menchén L
    Gastroenterology; 2007 May; 132(5):1791-803. PubMed ID: 17484875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
    Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y
    Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids.
    Baker PR; Schopfer FJ; O'Donnell VB; Freeman BA
    Free Radic Biol Med; 2009 Apr; 46(8):989-1003. PubMed ID: 19200454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production.
    Kleinhenz JM; Kleinhenz DJ; You S; Ritzenthaler JD; Hansen JM; Archer DR; Sutliff RL; Hart CM
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1647-54. PubMed ID: 19666848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of oleic acid on expression of adiponectin and its PPARgamma mechanism in 3T3-L1 adipocytes].
    Luo W; Lin J; Zhang Y; Ouyang J; Mao L
    Wei Sheng Yan Jiu; 2013 Mar; 42(2):245-9. PubMed ID: 23654101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conjugated fatty acid in obesity and inflammatory bowel disease.
    Yuan G; Chen X; Li D
    J Agric Food Chem; 2015 Feb; 63(7):1883-95. PubMed ID: 25634802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases.
    Venkataraman B; Ojha S; Belur PD; Bhongade B; Raj V; Collin PD; Adrian TE; Subramanya SB
    Phytother Res; 2020 Jul; 34(7):1530-1549. PubMed ID: 32009281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Da Silva S; Keita ÅV; Mohlin S; Påhlman S; Theodorou V; Påhlman I; Mattson JP; Söderholm JD
    Inflamm Bowel Dis; 2018 Mar; 24(4):792-805. PubMed ID: 29529198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.